Department of Medical Genetics, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
John P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, USA.
J Hum Genet. 2014 Jan;59(1):5-15. doi: 10.1038/jhg.2013.114. Epub 2013 Nov 7.
Massively parallel DNA-sequencing systems provide sequence of huge numbers of different DNA strands at once. These technologies are revolutionizing our understanding in medical genetics, accelerating health-improvement projects, and ushering to a fully understood personalized medicine in near future. Whole-exome sequencing (WES) is application of the next-generation technology to determine the variations of all coding regions, or exons, of known genes. WES provides coverage of more than 95% of the exons, which contains 85% of disease-causing mutations in Mendelian disorders and many disease-predisposing SNPs throughout the genome. The role of more than 150 genes has been distinguished by means of WES, and this statistics is quickly growing. In this review, the impacts of WES in medical genetics as well as its consequences leading to improve health care are summarized.
大规模平行 DNA 测序系统能够一次性对大量不同的 DNA 链进行测序。这些技术正在彻底改变我们对医学遗传学的理解,加速改善健康的项目,并在不久的将来迎来完全了解的个性化医疗。全外显子组测序(WES)是将下一代技术应用于确定已知基因的所有编码区域(外显子)的变异。WES 提供了超过 95%的外显子覆盖,其中包含孟德尔疾病中 85%的致病突变和整个基因组中许多导致疾病的 SNP。通过 WES 已经区分了超过 150 个基因的作用,并且这一统计数据正在迅速增长。在这篇综述中,总结了 WES 在医学遗传学中的影响以及导致改善医疗保健的后果。